Nivimedone
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161558This classification denotes a mast cell stabilizer with the molecular formula C11H9NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1M887244YI chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears US NIH Compound Identifier 64753. European Medicines Agency schedules Nivimedone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG. The term NIVIMEDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17). Most nations schedule nivimedone under HS 29147000 and SITC 51629. As of Q4 2014, NIVIMEDONE remains the US FDA Preferred Term for this commodity. Nivimedone bears US NLM identifiers UMLS ID C0068885 and NCI Concept Code C84021. SMILES: CC1=C(C=C2C(=C1)C(=O)C(C2=O)[N+](=O)[O-])C.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.